MENU

Multiple Myeloma
FAQ

Find answers to frequently asked questions about multiple myeloma.

Download FAQ

Understanding Your
Treatment

Prepare to ask your doctor the right questions about your treatment.

Download Treatment Questions

Myeloma
MVP

Create your Most Valuable Plan for dealing with multiple myeloma.

Download Your Plan

For physicians interested in learning more about multiple myeloma, please visit MyelomaRevealed.com. →

To hear powerful stories from patients, physicians and others, visit Blood Counts, a national effort in collaboration with StoryCorps. →

Patient Research and Advocacy Organizations

Research and advocacy organizations play a significant role in the multiple myeloma community. They provide patient support, raise funds for research and drive disease awareness, among other roles. Visit the patient research and advocacy organizations below and find important information and a support group near you.

Thank you!

We look forward to sharing updates in the future

Close window

Sign up to learn more and receive
updates from Myeloma Explained.

References

  1. National Cancer Institute. Cancer Stat Facts: Myeloma. Available at: https://seer.cancer.gov/statfacts/html/mulmy.html. Accessed on: September 11, 2019.
  2. Ailawadhi S, Swaika A, Advani P, et al. Current State of Patient Awareness and Participation in Care for Multiple Myeloma and the Psychophysical Impact of Treatment: An International Internet-Based Study. Blood. 2014;124:1294.
  3. Jakubowiak A. Management strategies for relapsed/refractory multiple myeloma: current clinical perspectives. Semin in Hematol. 2012;49 (Suppl 1):S16-S32.
  4. American Cancer Society. About Multiple Myeloma. Available at: https://www.cancer.org/content/dam/CRC/PDF/Public/8738.00.pdf. Accessed on: September 11, 2019.
  5. Multiple Myeloma Research Foundation. Multiple Myeloma Disease Overview. Available at: https://www.themmrf.org/wp-content/uploads/MMRF_Disease_Overview.pdf. Accessed on: September 11, 2019.
  6. American Cancer Society. Signs and Symptoms of Multiple Myeloma. Available at: https://www.cancer.org/cancer/multiple-myeloma/detection-diagnosis-staging/signs-symptoms.html. Accessed on: September 11, 2019.
  7. American Cancer Society. Risk Factors for Multiple Myeloma. Available at: https://www.cancer.org/cancer/multiple-myeloma/causes-risks-prevention/risk-factors.html. Accessed on: September 11, 2019.
  8. National Cancer Institute. Understanding Cancer Prognosis. Available at: https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis. Accessed on: September 11, 2019.
  9. Laubach J, Garderet L, Mahindra A, et al. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group. Leukemia. 2015; 30(5):1005-17.
  10. Durie BGM. MM Concise Review - 2017. Available at: www.myeloma.org. Accessed on: September 6, 2019.
  11. American Cancer Society. Drug Therapy for Multiple Myeloma. Available at: https://www.cancer.org/cancer/multiple-myeloma/treating/chemotherapy.html. Accessed on: September 6, 2019.
  12. MMRF. Treatment Overview. Available at: https://www.mmrf.org/wp-content/uploads/MMRF_Brochure_Treatment-Overview_092017.pdf. Accessed on: September 24, 2019.
  13. Multiple Myeloma Research Foundation. Standard Treatments. Available at: https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/. Accessed on: September 6, 2019.
  14. Quach H, Ritchie D, Stewart SK, et al. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia. 2010;24(1): 22-32.
  15. Terpos E, et al. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol. 2013;31(18):2347-57.
  16. American Cancer Society. What is Multiple Myeloma? Available at: https://www.cancer.org/content/dam/CRC/PDF/Public/8738.00.pdf. Accessed on: September 11, 2019.
  17. NIH. Iron-Deficiency Anemia. www.nhlbi.nih.gov. Accessed on: September 6, 2019.
  18. Bhowmik D, et al. Prevalence Of Renal Impairment In Patients With Multiple Myeloma: Analysis Of Real-World Database. Journal of the International Society for Pharmacoeconomic and Outcomes Research. 2016;9(3):A141.
  19. Blimark C, Holmberg E, Mellqvist UH, et al. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015;100 (1) 107-113.

You are now leaving MyelomaExplained.com and going to a website.

Would you like to proceed?

YesCancel

You are now leaving MyelomaExplained.com.

Amgen does not influence, control, or endorse the content on the site you are about to enter. Would you like to proceed?

YesCancel